Specific phage-displayed peptides discriminate different forms of neurocysticercosis by antibody detection in the serum samples

Parasite Immunology

Volumn 33, Issue 6, 2011, Pages 322-329

  Manhani, M N ^a   Ribeiro, V S ^a   Cardoso, R ^a   Ueira Vieira, C ^a   Goulart, L R ^a,b   Costa Cruz, J M ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diagnosis; Mimotopes; Neurocysticercosis; Phage display; Taenia solium

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN Y;

ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; HUMAN; METACESTODE; NEUROCYSTICERCOSIS; PEPTIDE ANALYSIS; PHAGE DISPLAY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; TAENIA SOLIUM;

ANIMALS; ANTIBODIES, HELMINTH; CHICKENS; HUMANS; IMMUNOGLOBULIN G; NEUROCYSTICERCOSIS; PARASITOLOGY; PEPTIDE LIBRARY; PEPTIDES; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SERUM; TAENIA SOLIUM;

GALLUS GALLUS; TAENIA SOLIUM;

EID: 79955736854     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2011.01283.x     Document Type: Article

References (43)

1. White AC Jr. Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 1997; 24: 101-115.
2. Kraft R. Cysticercosis: an emerging parasitic disease. Am Fam Physician 2007; 76: 91-96.
3. Pawlowski ZS. Control of neurocysticercosis by routine medical and veterinary services. Trans R Soc Trop Med Hyg 2008; 102: 228-232.
4. Del Brutto OH. Neurocysticercosis: up-dating in diagnosis and treatment. Neurologia 2005; 20: 412-418.
5. Furrows SJ, McCroddan J, Bligh WJ & Chiodini P. Lack of specificity of a single positive 50-kDa band in the electroimmunotransfer blot (EITB) assay for cysticercosis. Clin Microbiol Infect 2006; 12: 459-462.
6. San-juan Orta D. Clinical manifestations of neurocysticercosis. Neurologia 2009; 24: 331-335.
7. Sotelo J, Guerrero V & Rubio F. Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases. Arch Intern Med 1985; 145: 442-445.
8. Sahu PS, Parija SC, Narayan SK & Kumar D. Evaluation of an IgG-ELISA strategy using Taenia solium metacestode somatic and excretory-secretory antigens for diagnosis of neurocysticercosis revealing biological stage of the larvae. Acta Trop 2009; 110: 38-45.
9. Deckers N & Dorny P. Immunodiagnosis of Taenia solium taeniosis/cysticercosis. Trends Parasitol 2010; 26: 137-144.
10. Costa JM, Ferreira AW, Makino MM & Camargo ME. Spinal fluid immunoenzymatic assay (ELISA) for neurocysticercosis. Rev Inst Med Trop São Paulo 1982; 24: 337-341.
11. Shiguekawa KY, Mineo JR, de Moura LP & Costa-Cruz JM. ELISA and western blotting tests in the detection of IgG antibodies to Taenia solium metacestodes in serum samples in human neurocysticercosis. Trop Med Int Health 2000; 5: 443-449.
12. Tsang VC, Brand JA & Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989; 159: 50-59.
13. Chung JY, Bahk YY, Huh S, Kang SY, Kong Y & Cho SY. A recombinant 10-kDa protein of Taenia solium metacestodes specific to active neurocysticercosis. J Infect Dis 1999; 180: 1307-1315.
14. Molinari JL, Garcia-Mendoza E, de la Garza Y, Ramirez JA, Sotelo J & Tato P. Discrimination between active and inactive neurocysticercosis by metacestode excretory/secretory antigens of Taenia solium in an enzyme-linked immunosorbent assay. Am J Trop Med Hyg 2002; 66: 777-781.
15. Barcelos ISC, Ferreira MS, Moura LP, Biondi GF & Costa-Cruz JM. Use of the paired samples (cerebrospinal fluid and serum) in immunodiagnostic of active and inactive human neurocysticercosis. Mem Inst Oswaldo Cruz 2005; 100: 427-429.
16. Manhani MN, da Silva Ribeiro V, Oliveira Silva DA & Costa-Cruz JM. Specific IgG avidity in active and inactive human neurocysticercosis. Diagn Microbiol Infect Dis 2009; 65: 211-213.
17. Garcia HH, Harrison LJ, Parkhouse RM, et al. A specific antigen detection ELISA for the diagnosis of human neurocysticercosis. Trans R Soc Trop Med Hyg 1998; 92: 411-414.
18. Fleury A, Hernández M, Avila M, et al. Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis. J Neurol Neurosurg Psychiatry 2007; 78: 970-974.
19. Casey JL, Coley AM, Parisi K & Foley M. Peptide mimics selected from immune sera using phage display technology can replace native antigens in the diagnosis of Epstein-Barr virus infection. Protein Eng Des Sel 2009; 22: 85-91.
20. Scott JK & Smith GP. Searching for peptide ligands with an epitope library. Science 1990; 249: 386-390.
21. Park HY, Park HC & Yoon MY. Screening for peptides binding on Phytophthora capsici extracts by phage display. J Microbiol Methods 2009; 78: 54-58.
22. Manoutcharian K, Sotelo J, Garcia E, Cano A & Gevorkian G. Characterization of cerebrospinal fluid antibody specificities in neurocysticercosis using phage display peptide library. Clin Immunol 1999; 91: 117-121.
23. Deckers N, Saerens D, Kanobana K, et al. Nanobodies, a promising tool for species-specific diagnosis of Taenia solium cysticercosis. Int J Parasitol 2009; 39: 625-633.
24. Hell RC, Amim P, Andrade HM, et al. Immunodiagnosis of human neurocysticercosis using a synthetic peptide selected by phage-display. Clin Immunol 2009; 131: 129-138.
25. LeClaire RD, Hunt RE & Bavari S. Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination. Infect Immun 2002; 70: 2278-2281.
26. Abouzid K, Ndeboko B, Durantel S, et al. Genetic vaccination for production of DNA-designed antibodies specific to Hepadnavirus envelope proteins. Vaccine 2006; 24: 4615-4617.
27. Lee YC, Leu SJ, Hung HC, et al. A dominant antigenic epitope on SARS-CoV spike protein identified by an avian single-chain variable fragment (scFv)-expressing phage. Vet Immunol Immunopathol 2007; 117: 75-85.
28. Del Brutto OH, Wadia NH, Dumas M, Cruz M, Tsang VC & Schantz PM. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci 1996; 142: 1-6.
29. Willcox HP & Coura JR. A new design of the Baermann, Moraes, Coutinho's technique for the isolation of nematode larva. Mem Inst Oswaldo Cruz 1989; 84: 563-565.
30. Lowry VH, Rosebrouch NJ, Farr AL & Randal RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
31. Barbas CF III, Burton DR, Scott JK & Silverman GJ. Phage Display: A Laboratory Manual. New York, Cold Spring Harbor Laboratory Press, 2001: 738.
32. Bueno EC, Scheel CM, Vaz AJ, et al. Application of synthetic 8-kD and recombinant GP50 antigens in the diagnosis of neurocysticercosis by enzyme-linked immunosorbent assay. Am J Trop Med Hyg 2005; 72: 278-283.
33. Ferrer E, González LM, Martínez-Escribano JA, et al. Evaluation of recombinant HP6-Tsag, an 18kDa Taenia saginata oncospheral adhesion protein, for the diagnosis of cysticercosis. Parasitol Res 2007; 101: 517-525.
34. Zimic M, Pajuelo M, Rueda D, et al. Utility of a protein fraction with cathepsin L-Like activity purified from cysticercus fluid of Taenia solium in the diagnosis of human cysticercosis. Am J Trop Med Hyg 2009; 80: 964-970.
35. Bentley L, Fehrsen J, Jordaan F, Huismans H & du Plessis DH. Identification of antigenic regions on VP2 of African horsesickness virus serotype 3 by using phage-displayed epitope libraries. J Gen Virol 2000; 81: 993-1000.
36. Carlander D, Stålberg J & Larsson A. Chicken antibodies: a clinical chemistry perspective. Ups J Med Sci 1999; 104: 179-189.
37. Hoberg EP. Phylogeny of Taenia: species definitions and origins of human parasites. Parasitol Int 2006; 55(Suppl): S23-S30.
38. Ribeiro VS, Manhani MN, Cardoso R, Vieira CU, Goulart LR & Costa-Cruz JM. Selection of high affinity peptide ligands for detection of circulating antibodies in neurocysticercosis. Immunol Lett 2010; 129: 94-99.
39. Robles Y, González E, Govezensky T, et al. Isolation of the Taenia crassiceps antigens from a phage display cDNA library and evaluation of their use for diagnosis of neurocysticercosis. Clin Immunol 2005; 116: 265-270.
40. Loch U, Schranner I, Wanke R, et al. The chicken egg and antibody source. J Vet Med B 1986; 33: 609-919.
41. Barcelos ISC, Moura LP, Costa VP, Ferreira MS & Costa-Cruz JM. Taenia solium metacestode immunodominant peptides recognized by IgG antibodies in cerebrospinal fluid and serum paired samples from patients with active and inactive neurocysticercosis. Mem Inst Oswaldo Cruz 2007; 102: 713-717.
42. Montenegro T, Gilman RH, Castillo R, et al. The diagnostic importance of species-specific and cross-reactive components of Taenia solium, Echinococcus granulosus, and Hymenolepis nana. Rev Inst Med Trop Sao Paulo 1994; 36: 327-334.
43. Gonçalves FA, Machado GA, Oliveira HB, Rezende MT, Mineo JR & Costa-Cruz JM. Hydrophobic fraction of Taenia saginata metacestodes, rather than hydrophilic fraction, contains immunodominant markers for diagnosing human neurocysticercosis. Rev Soc Bras Med Trop 2010; 43: 254-259.